Last updated: July 17, 2026

Application No. 17/917,899

CAROTENOID SOLUTIONS AND USES THEREOF

Non-Final OA

Filed

Oct 07, 2022

Priority

Apr 09, 2020 — provisional 63/007,878 +1 more

Examiner

AZPURU, CARLOS A

Art Unit

1617

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

L.E.A.F. Holdings Group LLC

OA Round

1 (Non-Final)

Interview Optional

— +10.5% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 84% grant rate with +10.5% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 1286 resolved cases, 2023–2026

Examiner Intelligence

AZPURU, CARLOS A View full profile →

Grants 84% — above average

Career Allowance Rate

1076 granted / 1286 resolved

+23.7% vs TC avg

Moderate +10% lift

Without

With

+10.5%

Interview Lift

resolved cases with interview

Typical timeline

2y 7m

Avg Prosecution

31 currently pending

Career history

1312

Total Applications

across all art units

Statute-Specific Performance

§101

2.0%

-38.0% vs TC avg

§103

32.1%

-7.9% vs TC avg

§102

19.7%

-20.3% vs TC avg

§112

21.5%

-18.5% vs TC avg

Black line = Tech Center average estimate • Based on career data from 1286 resolved cases

Prosecution Timeline

Oct 07, 2022

Application Filed

May 07, 2024

Response after Non-Final Action

Feb 03, 2026

Examiner Interview (Telephonic)

Feb 10, 2026

Non-Final Rejection mailed

Jul 10, 2026

Response Filed

Precedent Cases

Applications granted by this same examiner with similar technology

18/014,867

Patent 12678448

POLYMERIC CARRIERS FOR DELIVERY OF THERAPEUTIC AGENTS

3y 6m to grant Granted Jul 14, 2026

18/022,724

Patent 12678536

BIOCOMPATIBLE POLYMER, BIOCOMPATIBLE COMPOSITIONS, SOL OR GEL, AND INJECTABLE COMPOSITION

3y 4m to grant Granted Jul 14, 2026

18/276,124

Patent 12673134

GELATIN-CONTAINING DEVICE

2y 11m to grant Granted Jul 07, 2026

17/854,914

Patent 12667545

Lyophilized Compositions of Phenobarbital Sodium Salt

4y 0m to grant Granted Jun 30, 2026

18/407,246

Patent 12661318

SYSTEMS AND METHODS FOR TARGETED BREAST CANCER THERAPIES

2y 5m to grant Granted Jun 23, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

84%

Grant Probability

94%

With Interview (+10.5%)

2y 7m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 1286 resolved cases by this examiner. Grant probability derived from career allowance rate.